Related Experiment Video
Updated: May 13, 2026

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
C3 glomerulopathies. A new perspective on glomerular diseases
Cristina Rabasco-Ruiz1, Ana Huerta-Arroyo, Jara Caro-Espada
1Servicio de Nefrología. Hospital Universitario 12 de Octubre. Madrid, Spain. crisrabasco@hotmail.com
Abstract:
Membranoproliferative glomerulonephritis denotes a general pattern of glomerular injury that is easily recognised by light microscopy. With additional studies, MPGN subgrouping is possible. For example, electron microscopy resolves differences in electron-dense deposition location, while immunofluorescence typically detects the composition of electron-dense deposits. A C3 glomerulopathy (C3G) is a recently described entity, a proliferative glomerulonephritis (usually but not always), with a MPGN pattern on light microscopy, with C3 staining alone on immunofluorescence, implicating hyperactivity of the alternative complement pathway. The evaluation of C3G in a patient should focus on the complement cascade, as deregulation of the alternative pathway and terminal complement cascade underlies pathogenesis. Although there are no specific treatments currently available for C3G, a better understanding of their pathogenesis would set the stage for the possible use of anti-complement drugs, as eculizumab. In this review, we summarise the pathogenesis of the C3 glomerulopathies, focusing on the role of complement, the patient cohorts recently reported and options of treatment up to the current moment.
Insights
C3 glomerulopathy (C3G) involves the alternative complement pathway, causing kidney injury. Understanding C3G pathogenesis is key to developing new treatments targeting complement hyperactivity.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Membranoproliferative glomerulonephritis (MPGN) is a pattern of kidney injury identifiable by light microscopy.
- Subgrouping MPGN requires advanced techniques like electron microscopy and immunofluorescence to analyze electron-dense deposits.
- C3 glomerulopathy (C3G) is a distinct entity characterized by MPGN on light microscopy and isolated C3 deposition on immunofluorescence.
Purpose of the Study:
- To review the pathogenesis of C3 glomerulopathies (C3G).
- To highlight the critical role of the complement system, particularly the alternative pathway, in C3G.
- To discuss recent patient cohorts and current/potential treatment options.
Main Methods:
- Review of existing literature on C3 glomerulopathy.
- Analysis of diagnostic criteria including light microscopy, electron microscopy, and immunofluorescence.
- Focus on complement cascade dysregulation in C3G pathogenesis.
Main Results:
- C3G pathogenesis is linked to hyperactivity of the alternative and terminal complement pathways.
- Isolated C3 deposition on immunofluorescence is a hallmark of C3G.
- Understanding complement dysregulation is crucial for C3G management.
Conclusions:
- C3G is a distinct glomerulopathy driven by complement dysregulation.
- Further research into complement pathways may lead to targeted therapies.
- Anti-complement drugs like eculizumab show potential for C3G treatment.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome II : Assessment and Medical Management

